Literature DB >> 4405931

Allopurinol and cytotoxic drugs. Interaction in relation to bone marrow depression. Boston Collaborative Drug Surveillance Program.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4405931

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Pharmacokinetic drug interactions of commonly used anticancer drugs.

Authors:  F M Balis
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  L B Grochow; M Colvin
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

Review 3.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

4.  The influence of allopurinol and size of dose on the metabolism of phenylbutazone in patients with gout.

Authors:  D Horwitz; S S Thorgeirsson; J R Mitchell
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  M J Moore
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of allopurinol.

Authors:  G A Murrell; W G Rapeport
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

7.  [Reversible azathioprine associated dysmyeloproliferative syndrome after kidney allotransplantation].

Authors:  F Bammatter; U Binswanger; J Fehr
Journal:  Klin Wochenschr       Date:  1987-07-01

Review 8.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

9.  Immunotherapeutics for autoimmune encephalopathies and dementias.

Authors:  Andrew McKeon
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.972

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.